BSJ-03-123 is primarily used in the field of medicinal chemistry as a potential therapeutic agent. It has shown promise in preclinical studies for targeting specific disease pathways, particularly in oncology. Researchers are exploring its efficacy in inhibiting certain enzymes or proteins involved in cancer cell proliferation, making it a candidate for developing targeted cancer therapies. Additionally, its unique chemical structure allows for further modification, enabling scientists to optimize its pharmacological properties, such as bioavailability and selectivity. Beyond oncology, BSJ-03-123 is also being investigated for its potential applications in treating inflammatory and autoimmune disorders due to its ability to modulate immune responses. Its versatility in interacting with biological targets makes it a valuable compound for drug discovery and development.